Clindamycin Hydrochloride
- Product NDC
- 71335-0866
- 11-digit product format
- 713350866
- Labeler code
- 71335
- Product ID
- 71335-0866_7c9b9b26-93c2-4d26-b5c1-8e6db04f4193
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA063083
- Marketing category
- ANDA
- Marketing start
- 1991-07-31
- Marketing end
- 2022-05-31
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0866-1 | 71335086601 | 90 CAPSULE in 1 BOTTLE (71335-0866-1) | 90 capsule | 2018-06-15 | 2022-05-31 | No | No | Current |
| 71335-0866-2 | 71335086602 | 40 CAPSULE in 1 BOTTLE (71335-0866-2) | 40 capsule | 2021-12-27 | 2022-05-31 | No | No | Current |
| 71335-0866-3 | 71335086603 | 56 CAPSULE in 1 BOTTLE (71335-0866-3) | 56 capsule | 2018-07-20 | 2022-05-31 | No | No | Current |